OpenURL Connection Search

Select item for more details and to access through your institution.

Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study.
Published in:
Breast Cancer Research & Treatment, 2022, v. 195, n. 3, p. 341, doi. 10.1007/s10549-022-06669-2
By:
- Walsh, Elaine M.;
- Gucalp, Ayca;
- Patil, Sujata;
- Edelweiss, Marcia;
- Ross, Dara S.;
- Razavi, Pedram;
- Modi, Shanu;
- Iyengar, Neil M.;
- Sanford, Rachel;
- Troso-Sandoval, Tiffany;
- Gorsky, Mila;
- Bromberg, Jacqueline;
- Drullinsky, Pamela;
- Lake, Diana;
- Wong, Serena;
- DeFusco, Patricia Ann;
- Lamparella, Nicholas;
- Gupta, Ranja;
- Tabassum, Tasmila;
- Boyle, Leigh Ann
Publication type:
Article
Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients.
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2016, v. 23, n. 5, p. 1515, doi. 10.1245/s10434-015-5020-3
By:
- Sanford, Rachel;
- Lei, Xiudong;
- Barcenas, Carlos;
- Mittendorf, Elizabeth;
- Caudle, Abigail;
- Valero, Vicente;
- Tripathy, Debu;
- Giordano, Sharon;
- Chavez-MacGregor, Mariana
Publication type:
Article
Investigation of the correlation of serum IL‐31 with severity of dermatitis in an experimental model of canine atopic dermatitis using beagle dogs.
Published in:
Veterinary Dermatology, 2018, v. 29, n. 1, p. 69, doi. 10.1111/vde.12500
By:
- Marsella, Rosanna;
- Ahrens, Kim;
- Sanford, Rachel
Publication type:
Article
Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial.
Published in:
European Heart Journal, 2023, v. 44, n. 46, p. 4878, doi. 10.1093/eurheartj/ehad085
By:
- Scott, Jessica M;
- Lee, Jasme;
- Herndon, James E;
- Michalski, Meghan G;
- Lee, Catherine P;
- O'Brien, Kelly A;
- Sasso, John P;
- Yu, Anthony F;
- Rowed, Kylie A;
- Bromberg, Jacqueline F;
- Traina, Tiffany A;
- Gucalp, Ayca;
- Sanford, Rachel A;
- Gajria, Devika;
- Modi, Shanu;
- Comen, Elisabeth A;
- D'Andrea, Gabriella;
- Blinder, Victoria S;
- Eves, Neil D;
- Peppercorn, Jeffrey M
Publication type:
Article
Agonistic character displacement in social cognition of advertisement signals.
Published in:
Animal Cognition, 2017, v. 20, n. 2, p. 267, doi. 10.1007/s10071-016-1046-6
By:
- Pasch, Bret;
- Sanford, Rachel;
- Phelps, Steven
Publication type:
Article
First-in-Human Evaluation of Site-Specifically Labeled 89Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.
Published in:
Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266392
By:
- Yeh, Randy;
- O'Donoghue, Joseph A.;
- Jayaprakasam, Vetri Sudar;
- Mauguen, Audrey;
- Min, Ryan;
- Park, Sue;
- Brockway, Julia P.;
- Bromberg, Jacqueline F.;
- Zhi, W. Iris;
- Robson, Mark E.;
- Sanford, Rachel;
- Modi, Shanu;
- Agnew, Brian J.;
- Lyashchenko, Serge K.;
- Lewis, Jason S.;
- Ulaner, Gary A.;
- Zeglis, Brian M.
Publication type:
Article
First-in-Human Evaluation of Site-Specifically Labeled 89Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.
Published in:
Journal of Nuclear Medicine, 2024, v. 65, n. 3, p. 386, doi. 10.2967/jnumed.123.266392
By:
- Yeh, Randy;
- O'Donoghue, Joseph A.;
- Jayaprakasam, Vetri Sudar;
- Mauguen, Audrey;
- Min, Ryan;
- Park, Sue;
- Brockway, Julia P.;
- Bromberg, Jacqueline F.;
- Zhi, W. Iris;
- Robson, Mark E.;
- Sanford, Rachel;
- Modi, Shanu;
- Agnew, Brian J.;
- Lyashchenko, Serge K.;
- Lewis, Jason S.;
- Ulaner, Gary A.;
- Zeglis, Brian M.
Publication type:
Article
First-in-Human Evaluation of Site-Specifically Labeled 89Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.
Published in:
Journal of Nuclear Medicine, 2024, v. 65, n. 2, p. 1, doi. 10.2967/jnumed.123.266392
By:
- Yeh, Randy;
- O'Donoghue, Joseph A.;
- Jayaprakasam, Vetri Sudar;
- Mauguen, Audrey;
- Min, Ryan;
- Park, Sue;
- Brockway, Julia P.;
- Bromberg, Jacqueline F.;
- Zhi, W. Iris;
- Robson, Mark E.;
- Sanford, Rachel;
- Modi, Shanu;
- Agnew, Brian J.;
- Lyashchenko, Serge K.;
- Lewis, Jason S.;
- Ulaner, Gary A.;
- Zeglis, Brian M.
Publication type:
Article
High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumors.
Published in:
2015
By:
- Sanford, Rachel A.;
- Song, Juhee;
- Gutierrez‐Barrera, Angelica M.;
- Profato, Jessica;
- Woodson, Ashley;
- Litton, Jennifer Keating;
- Bedrosian, Isabelle;
- Albarracin, Constance T.;
- Valero, Vicente;
- Arun, Banu
Publication type:
journal article
Parallel Evolution and Lineage-Specific Expansion of RNA Editing in Ctenophores.
Published in:
Integrative & Comparative Biology, 2015, v. 55, n. 6, p. 1111, doi. 10.1093/icb/icv065
By:
- Kohn, Andrea B.;
- Sanford, Rachel S.;
- Yoshida, Masa-aki;
- Moroz, Leonid L.
Publication type:
Article
DNA Methylation in Basal Metazoans: Insights from Ctenophores.
Published in:
Integrative & Comparative Biology, 2015, v. 55, n. 6, p. 1096, doi. 10.1093/icb/icv086
By:
- Dabe, Emily C.;
- Sanford, Rachel S.;
- Kohn, Andrea B.;
- Bobkova, Yelena;
- Moroz, Leonid L.
Publication type:
Article
Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity
Published in:
BMC Cancer, 2015, v. 15, n. 1, p. 267, doi. 10.1186/s12885-015-1298-6
By:
- Stanton, Sasha E;
- Ward, Maureen M;
- Christos, Paul;
- Sanford, Rachel;
- Lam, Christina;
- Cobham, Marta V;
- Donovan, Diana;
- Scheff, Ronald J;
- Cigler, Tessa;
- Moore, Anne;
- Vahdat, Linda T;
- Lane, Maureen E;
- Chuang, Ellen
Publication type:
Article
Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity.
Published in:
2015
By:
- Stanton, Sasha E;
- Ward, Maureen M;
- Christos, Paul;
- Sanford, Rachel;
- Lam, Christina;
- Cobham, Marta V;
- Donovan, Diana;
- Scheff, Ronald J;
- Cigler, Tessa;
- Moore, Anne;
- Vahdat, Linda T;
- Lane, Maureen E;
- Chuang, Ellen
Publication type:
journal article

Found: 13

Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study.

Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients.

Investigation of the correlation of serum IL‐31 with severity of dermatitis in an experimental model of canine atopic dermatitis using beagle dogs.

Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial.

Agonistic character displacement in social cognition of advertisement signals.

First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.

First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.

First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.

High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumors.

Parallel Evolution and Lineage-Specific Expansion of RNA Editing in Ctenophores.

DNA Methylation in Basal Metazoans: Insights from Ctenophores.

Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity.